# Maharashtra FDA cancels InduCare Pharma license over contaminated drugs 2026-08-08T06:44:51+00:00 | Governance | Indian Opinion Desk Corroboration: 1 independent outlet The Maharashtra Food and Drug Administration on August 6 permanently cancelled the manufacturing licence of Pune-based InduCare Pharma Pvt. Ltd. after six Ayurvedic medicines failed quality tests. Samples of Sinhanad Guggul and Punarnavadi Mandur had fungal growth. Hingvastak Churna and Triphala Churna contained insects, larvae, and other foreign impurities. Triphala Guggul and Kanchanar Guggul exceeded microbial limits. A joint inspection found incomplete batch records, missing ingredients, poor sanitation, damaged equipment, and no pest-control documentation. The FDA said the company violated the Drugs and Cosmetics Act and Good Manufacturing Practice norms. Commissioner Tukaram Mundhe said strict action will be taken against any manufacturer showing negligence on drug quality. ## Coverage - thehindu.com Tags: Ayurvedic medicines, drug quality, FDA, GMP violations, license cancellation, Maharashtra Canonical: https://indianopinion.org/maharashtra-fda-cancels-inducare-pharma-license-over-contaminated-drugs/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/maharashtra-fda-cancels-inducare-pharma-license-over-contaminated-drugs/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.